Pharma Expert Series - Sakti Chakraborty

Loading player...
Sakti Chakraborty (Ex - Lupin India Business Head) speaks to Anshuman Gupta, pharma analyst at Investec India about the trends that will be seen in the pharma sector, the challenges in the demand - supply for medicines across India and what changes in behaviour the industry will notice due to the COVID19 protocols.
A veteran in the Pharma sector, Mr. Chakraborty has led a successful and a greatly accomplished career spanning more than four decades with major pharma giants like Aristo, Alkem, Wockhardt & Lupin. Before stepping out to start his own venture (Ergos Life Sciences), Mr. Sakti was the Lupin India Business head for 17 years (until 2017) where he scaled up the cos business to new heights.
1 May 2020 English South Africa Business · Investing

Other recent episodes

Rising Stress in MFI - A Perspective from Credit Rating Agency

As of March 2024, the Gross loan portfolio of Micro Finance industry has grown to Rs 4.42 lakh crore, up 26.8% over the previous year. Though active loans have grown 14% YoY, the Average ticket size has also increased by 12% YoY. While the industry witnessed best of asset quality…
31 Oct 2024 52 min